Compounded mazdutide is not currently available from research chemical suppliers or compounding pharmacies in the way that semaglutide and tirzepatide are
Thats why many obesity specialists view these drugs as short-term tools , not permanent solutions
Clinical trials show visceral fat reductions of 15-18% with Tesamorelin treatment, even without significant changes in overall body weight
A provider may consider: IGF-1 Fasting glucose A1C Lipids Thyroid markers Liver and kidney markers Blood pressure Sleep quality Current medications Personal and family health history Lab review helps determine whether growth hormone support is appropriate, whether a safer alternative should be considered, and how treatment should be monitored over time
Tirzepatide (GLP-1 + GIP): This is a newer, dual-action medication and the same active ingredient as Mounjaro and Zepbound
Ask directly: "Will I receive brand-name Zepbound or Wegovy online, or a compounded version?" Compounded GLP-1s are not FDA-reviewed for safety, effectiveness, or quality, and with the drug shortages resolved, the regulatory basis for mass compounding has narrowed considerably